MONECO Advisors LLC Acquires Shares of 3,128 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

MONECO Advisors LLC purchased a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the fourth quarter, Holdings Channel reports. The institutional investor purchased 3,128 shares of the company’s stock, valued at approximately $245,000.

A number of other large investors have also recently made changes to their positions in GEHC. LGT Financial Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after acquiring an additional 251 shares during the period. Capital Performance Advisors LLP bought a new position in shares of GE HealthCare Technologies in the third quarter worth $26,000. Ashton Thomas Securities LLC bought a new position in shares of GE HealthCare Technologies in the third quarter worth $26,000. Darwin Wealth Management LLC bought a new position in shares of GE HealthCare Technologies in the third quarter worth $31,000. Finally, Continuum Advisory LLC boosted its holdings in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after acquiring an additional 168 shares during the period. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Trading Up 0.3 %

NASDAQ GEHC opened at $90.81 on Wednesday. The stock’s 50-day simple moving average is $85.49 and its two-hundred day simple moving average is $86.01. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $41.53 billion, a price-to-earnings ratio of 20.97, a PEG ratio of 3.19 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.